Abstract
31P nuclear magnetic resonance (NMR) spectroscopy was used to measure the rate of acyl transfer from phosphatidylcholine (lecithin, PC) in whole plasma and in high density lipoprotein (HDL). Spectral deconvolution was used to resolve overlapping resonances in the31P NMR spectra of the phospholipids. Mean values of the acyl group transfer rates from PC in plasma and HDL were 36 μmol L−1h−1 and 19 μmol L−1h−1, respectively. The reciprocal nature of the decrease in the spectral peak intensities of PC, compared to the increase in the intensities of the lysolecithin (lysoPC) peaks, suggested a substrate/product relationship consistent with the action of lecithin:cholesterol acyltransferase (LCAT), the enzyme responsible for the esterification of free cholesterol in plasma. LCAT involvement was confirmed by measuring the cholesterol esterification rate based on the13C NMR spectra obtained on lipid extracts from plasma that had been incubated at 37°C. Within experimental error, the rate of lysoPC formation in plasma was shown to be equal to that of cholesteryl ester formation.
Similar content being viewed by others
Abbreviations
- CETP:
-
cholesteryl ester transfer protein
- DTNB:
-
5,5-dithiobis(-2-nitrobenzoic acid)
- GPC:
-
glycerophosphorylcholine
- HDL:
-
high density lipoprotein
- LCAT:
-
lecithin:cholesterol acyltransferase
- LDL:
-
low density lipoprotein
- lysoPC:
-
lysophosphatidylcholine
- PC:
-
phosphatidylcholine
- SPH:
-
sphingomyelin
References
Glomset, J.A. (1970)Am. J. Clin. Nutr. 23, 1129–1136.
Glomset, J.A., and Norum, K.R. (1973)Adv. Lipid Res. 11, 1–65.
Albers, J.J., Adolphson, J.L., and Chen, C.H. (1981)J. Clin. Invest. 67, 141–148.
Akanuma, X., and Glomset, J.A. (1968)J. Lipid Res. 9, 620–626.
Glomset, J.A., Norum, K.R., Nicholas, A.V., Forte, T., King, W.C., Albers, J., Mitchel, C.D., Applegate, K.R., and Gjone, E. (1974)Scand. J. Clin. Lab. Invest. 33 (Suppl. 137), 165–172.
Fielding, C.J., Shore, V.G., and Fielding, P.E. (1972)Biochem. Biophys. Res. Commun. 46, 1493–1498.
Chen, C.H., and Albers, J.J. (1982)J. Lipid Res. 23, 680–691.
Fielding, C.J. (1986)Methods Enzymol. 129, 783–790.
Rajaram, O.V., and Barter, P.J. (1985)Biochim. Biophys. Acta 835, 41–49.
Tall, A.R. (1986)J. Lipid Res. 27, 361–367.
Fielding, P.E., and Fielding, C.J. (1980)Proc. Natl. Acad. Sci. USA 77, 3327–3330.
Albers, J.J., Tollefson, T.H., Chen, C., and Steinmetz, A. (1984)Arteriosclerosis 4, 49–58.
Groener, J.E.M., Pelton, R.W., and Kostner, G.M. (1986)Clin. Chem. 32, 283–286.
Albers, J.J., Chen, C., and Lacko, A.G. (1986)Methods Enzymol. 129, 763–783.
Warnick, G.R., Benderson, J., and Albers, J.J. (1982)Clin. Chem. 28, 1379–1388.
Bligh, E.G., and Dyer, W.J., (1959)Can. J. Biochem. Physiol. 37, 911–917.
Homer, J., and Roberts, J.K. (1989)J. Magn. Reson. 81, 484–490.
Kuchel, P.W. (1989) inAnalytical NMR (Field, L.D., and Sternhell, S., eds.) pp. 157–219, John Wiley & Sons, Chichester.
Albers, J.J., Chen, C.H., and Adolphson, J.L. (1981)J. Lipid Res. 22, 1206–1213.
Channon, K.M., Clegg, R.J., Bhatnagar, D., Ishola, M., Arrols, S., and Durrington, P.N. (1990)Atherosclerosis 80, 217–226.
Subbaiah, P.V., Albers, J.J., Chen, C.H., and Bagdade, J.D. (1980)J. Biol. Chem. 255, 9275–9280.
Subbaiah, P.V. (1986)Methods Enzymol. 129, 790–797.
Aron, L., Jones, S., and Fielding, C.J. (1978)J. Biol. Chem. 253, 7220–7226.
Piran, U., and Nishida, T. (1976)J. Biochem. 80, 887–889.
Jonas, A. (1987) inPlasma Lipoproteins (Gotto, Jr., A.M., ed.) pp. 299–333, Elsevier, Amsterdam.
Brasure, E.H., Henderson, T.O., and Glonek, T. (1978)Biochemistry 17, 3934–3938.
Steinbrecher, U.P., and Prichard, P.H. (1989)J. Lipid Res. 30, 305–315.
Reisfeld, N., Lichtenberg, D., Dagan, A., and Yedgar, S. (1993)FEBS Lett. 315, 267–270.
Bradamante, S., Barchiesi, E., Barenghi, L., and Zoppi, F. (1990)Anal. Biochem. 185, 299–303.
Smith, E.L., Hill, R.L., Lehman, I.R., Lefkowitz, R.J., Handler, P., and White, A. (1983)Principles of Biochemistry: Mammalian Biochemistry, 7th edn., pp. 4–5, McGraw-Hill, New York.
James, T.L. (1975)Nuclear Magnetic Resonance in Biochemistry, 1st edn., pp. 1–14, Academic Press, New York.
Gent, M.P.N., and Prestegard, J.H. (1974)Biochemistry 13, 4027–4033.
Berden, J.A., Cullis, P.R., Hoult, D.I., McLaughlin, A.C., Radda, G.K., and Richards, R.E. (1974)FEBS Lett. 46, 55–58.
Henderson, T.O., Kruski, A.W., Davis, L.G., Glonek, T., and Scanu, A.M. (1975)Biochemistry 14, 1915–1920.
Glonek, T., Henderson, T.O., Kruski, A.W., and Scanu, A.M. (1974)Biochim. Biophys. Acta 348, 155–161.
London, E., and Feigenson, G.W. (1979)J. Lipid Res. 20 408–412.
Casu, M., Lai, A., Pilia, A., Casti, G., Zedda, S., and Gibbons, W.A. (1992)Arch. Gerontol. Geriatr. Suppl. 3, 111–122.
Author information
Authors and Affiliations
About this article
Cite this article
Nouri-Sorkhabi, M.H., Sullivan, D.R., Roberts, D.C. et al. A31P nuclear magnetic resonance investigation of acyl group transfer from phosphatidylcholine to yield lysophosphatidylcholine in human plasma. Lipids 29, 183–188 (1994). https://doi.org/10.1007/BF02536727
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536727